MYQORZO® (aficamten) is a cardiac myosin inhibitor approved in the U.S., China and European Union, United Kingdom and Canada for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
To learn more about how endometriosis causes pain at the molecular level, Yale School of Medicine researchers studied biopsies from patients with either symptomatic or asymptomatic endometriosis.
[...]. This is an abstract of the document. To keep reading, click here and get access to the original version. AttachmentsOriginal document Permalink. Disclaimer ... (noodl.
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules.